Trials / Not Yet Recruiting
Not Yet RecruitingNCT06551376
LATE LUTEAL PHASE VS. CONVENTIONAL EARLY FOLLICULAR PHASE START IN IVF
IVF CYCLE SCHEDULING WITH LATE LUTEAL PHASE VS. CONVENTIONAL EARLY FOLLICULAR PHASE START TO AVOID WEEKENDS RETRIEVALS: PROOF OF CONCEPT
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Clinia de fertilización Asistida en el Hospital ABC · Academic / Other
- Sex
- Female
- Age
- 20 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
To compare cycle outcomes after scheduling with the standard early follicular phase (EFP) versus late luteal phase (LLP) in patients undergoing GnRH antagonist cycles.
Detailed description
Objective To compare cycle outcomes after scheduling with the standard early follicular phase (EFP) versus late luteal phase (LLP) in patients undergoing GnRH antagonist cycles. Design Multicentric prospective non-randomized study Setting Two university-affiliated private assisted reproduction centers. Patient(s) Regularly cycling women aged ≤40 years with fewer than one previous IVF attempts were enrolled. Previous low responses to controlled ovarian hyperstimulation, ovarian surgery, or polycystic ovary were exclusion criteria. Intervention(s) Twenty patients started controlled ovarian stimulation (COS) after spontaneous menses; similarly, twenty patients started stimulation on the Friday previous to a spontaneous menses (at the end of late luteal phase), regardless of cycle day. Main Outcome Measure(s) Primary outcome: number of mature oocytes retrieved. Secondary outcomes: fertilization rate, viable embryo rate per oocyte retrieved, cancellation rate, and clinical pregnancy outcomes from FET cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ovarian Stimulation Start | To compare ovarian response accordin to ovarian stimualtion start |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
- First posted
- 2024-08-13
- Last updated
- 2024-08-13
Source: ClinicalTrials.gov record NCT06551376. Inclusion in this directory is not an endorsement.